Harper SJ - Search Results

1

Vascular Endothelial Growth Factor-A165b Is Protective and Restores Endothelial Glycocalyx in Diabetic Nephropathy.

Oltean S, Qiu Y, Ferguson JK, Stevens M, Neal C, Russell A, Kaura A, Arkill KP, Harris K, Symonds C, Lacey K, Wijeyaratne L, Gammons M, Wylie E, Hulse RP, Alsop C, Cope G, Damodaran G, Betteridge KB, Ramnath R, Satchell SC, Foster RR, Ballmer-Hofer K, Donaldson LF, Barratt J, Baelde HJ, Harper SJ, Bates DO, Salmon AH. Oltean S, et al. Among authors: harper sj. J Am Soc Nephrol. 2015 Aug;26(8):1889-904. doi: 10.1681/ASN.2014040350. Epub 2014 Dec 26. J Am Soc Nephrol. 2015. PMID: 25542969 Free PMC article.

2

Angiopoietin-1 is normally expressed by periendothelial cells.

Satchell SC, Harper SJ, Mathieson PW. Satchell SC, et al. Among authors: harper sj. Thromb Haemost. 2001 Dec;86(6):1597-8. Thromb Haemost. 2001. PMID: 11776343 No abstract available.

3

Human podocytes express angiopoietin 1, a potential regulator of glomerular vascular endothelial growth factor.

Satchell SC, Harper SJ, Tooke JE, Kerjaschki D, Saleem MA, Mathieson PW. Satchell SC, et al. Among authors: harper sj. J Am Soc Nephrol. 2002 Feb;13(2):544-550. doi: 10.1681/ASN.V132544. J Am Soc Nephrol. 2002. PMID: 11805186

4

Elevated plasma vascular endothelial growth factor levels in non-diabetic predialysis uraemia.

Harper SJ, Downs L, Tomson CR, Dwight JS, Bolton C. Harper SJ, et al. Nephron. 2002 Mar;90(3):341-3. doi: 10.1159/000049071. Nephron. 2002. PMID: 11867956

5

Human uremic plasma increases microvascular permeability to water and proteins in vivo.

Harper SJ, Tomson CR, Bates DO. Harper SJ, et al. Kidney Int. 2002 Apr;61(4):1416-22. doi: 10.1046/j.1523-1755.2002.00252.x. Kidney Int. 2002. PMID: 11918748 Free article.

6

VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma.

Bates DO, Cui TG, Doughty JM, Winkler M, Sugiono M, Shields JD, Peat D, Gillatt D, Harper SJ. Bates DO, et al. Among authors: harper sj. Cancer Res. 2002 Jul 15;62(14):4123-31. Cancer Res. 2002. PMID: 12124351

7

ZM323881, a novel inhibitor of vascular endothelial growth factor-receptor-2 tyrosine kinase activity.

Whittles CE, Pocock TM, Wedge SR, Kendrew J, Hennequin LF, Harper SJ, Bates DO. Whittles CE, et al. Among authors: harper sj. Microcirculation. 2002 Dec;9(6):513-22. doi: 10.1038/sj.mn.7800164. Microcirculation. 2002. PMID: 12483548

8

Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes.

Foster RR, Hole R, Anderson K, Satchell SC, Coward RJ, Mathieson PW, Gillatt DA, Saleem MA, Bates DO, Harper SJ. Foster RR, et al. Among authors: harper sj. Am J Physiol Renal Physiol. 2003 Jun;284(6):F1263-73. doi: 10.1152/ajprenal.00276.2002. Epub 2003 Mar 4. Am J Physiol Renal Physiol. 2003. PMID: 12620928 Free article.

9

Endothelial permeability in uremia.

Harper SJ, Bates DO. Harper SJ, et al. Kidney Int Suppl. 2003 May;(84):S41-4. doi: 10.1046/j.1523-1755.63.s84.15.x. Kidney Int Suppl. 2003. PMID: 12694306 Free article. Review.

10

Regulation of vascular permeability by vascular endothelial growth factors.

Bates DO, Harper SJ. Bates DO, et al. Among authors: harper sj. Vascul Pharmacol. 2002 Nov;39(4-5):225-37. doi: 10.1016/s1537-1891(03)00011-9. Vascul Pharmacol. 2002. PMID: 12747962 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

231 results

Search Page